EDAP TMS | EDAP - Cost Of Sales

Stock Price
4.34
Daily Change
-0.09 -1.92%
Monthly
6.37%
Yearly
69.52%
Q1 Forecast
4.59

EDAP TMS reported EUR9.22M in Cost of Sales for its fiscal quarter ending in June of 2025.





Cost Of Sales Change Date
AngioDynamics USD 33.15M 208K Feb/2025
Boston Scientific USD 1.84B 82M Dec/2025
EDAP TMS EUR 9.22M 1.36M Jun/2025
Henry Schein USD 2.44B 62M Dec/2025
Medtronic USD 3.61B 83M Dec/2025
Veracyte USD 39.28M 1.93M Dec/2025